NCT/Study#
NCT04919811 /
AB-106-G208
Taletrectinib In ROS1 Positive Lung Cancer Phase 2 Global Study
DISEASE GROUP:
Lung Cancer Clinical Trials
current phase:
II
STUDY STATUS:
Active
Location:
For More information:
Call 201-518-3587
